The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis. The test ...
Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...
Roche’s point-of-care polymerase chain reaction (PCR) test for pertussis and other Bordetella infections has received ...
The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...
See how QIAGEN’s flexible pipetting technologies optimize PCR sample preparation, enabling consistent results and faster ...
How can doctors talk about the net benefits of COVID shots if they won’t acknowledge the worst risk? On the Friday after ...
Researchers develop a molecular testing-based fast-throughput method for the rapid and early detection of Salmonella ...
Designed for use in doctor’s offices, clinics and emergency rooms, the PCR diagnostic aims to deliver results in fewer than ...
Roche AG received regulatory clearance from the U.S. and European authorities for a new diagnostic test that detects ...
Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough: Basel Wednesday, December ...
Roche Receives FDA Clearance With CLIA Waiver And CE Mark For Its First Point-Of-Care Test For Diagnosing Bordetella Infections, Including Whooping Cough (Pertussis). <li /> The point-of-care test ...